BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27292638)

  • 1. A Positive Regulatory Loop between a Wnt-Regulated Non-coding RNA and ASCL2 Controls Intestinal Stem Cell Fate.
    Giakountis A; Moulos P; Zarkou V; Oikonomou C; Harokopos V; Hatzigeorgiou AG; Reczko M; Hatzis P
    Cell Rep; 2016 Jun; 15(12):2588-96. PubMed ID: 27292638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
    Yokota K; Tanaka Y; Harada H; Kaida T; Nakamoto S; Soeno T; Fujiyama Y; Yokota M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4826-4834. PubMed ID: 31549316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
    Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
    Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascl2 acts as an R-spondin/Wnt-responsive switch to control stemness in intestinal crypts.
    Schuijers J; Junker JP; Mokry M; Hatzis P; Koo BK; Sasselli V; van der Flier LG; Cuppen E; van Oudenaarden A; Clevers H
    Cell Stem Cell; 2015 Feb; 16(2):158-70. PubMed ID: 25620640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Zinc Finger Transcription Factor PLAGL2 Enhances Stem Cell Fate and Activates Expression of ASCL2 in Intestinal Epithelial Cells.
    Strubberg AM; Veronese Paniagua DA; Zhao T; Dublin L; Pritchard T; Bayguinov PO; Fitzpatrick JAJ; Madison BB
    Stem Cell Reports; 2018 Aug; 11(2):410-424. PubMed ID: 30017821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncogenic function of PLAGL2 is mediated via ASCL2 and IGF2 and a Wnt-independent mechanism in colorectal cancer.
    Fischer AD; Veronese Paniagua DA; Swaminathan S; Kashima H; Rubin DC; Madison BB
    Am J Physiol Gastrointest Liver Physiol; 2023 Aug; 325(2):G196-G211. PubMed ID: 37310750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-spondin1/Wnt-enhanced Ascl2 autoregulation controls the self-renewal of colorectal cancer progenitor cells.
    Ye J; Liu S; Shang Y; Chen H; Wang R
    Cell Cycle; 2018; 17(8):1014-1025. PubMed ID: 29886802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
    Basu S; Gavert N; Brabletz T; Ben-Ze'ev A
    Cancer Lett; 2018 Jun; 424():9-18. PubMed ID: 29551399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.
    Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A
    Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entopic overexpression of Ascl2 does not accelerate tumourigenesis in ApcMin mice.
    Reed KR; Tunster SJ; Young M; Carrico A; John RM; Clarke AR
    Gut; 2012 Oct; 61(10):1435-8. PubMed ID: 22138533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA SNHG1 promotes cell proliferation and tumorigenesis in colorectal cancer
    Qi H; Wang J; Wang F; Ma H
    Pharmazie; 2017 Jul; 72(7):395-401. PubMed ID: 29441936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ validation of an intestinal stem cell signature in colorectal cancer.
    Ziskin JL; Dunlap D; Yaylaoglu M; Fodor IK; Forrest WF; Patel R; Ge N; Hutchins GG; Pine JK; Quirke P; Koeppen H; Jubb AM
    Gut; 2013 Jul; 62(7):1012-23. PubMed ID: 22637696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia.
    Jubb AM; Chalasani S; Frantz GD; Smits R; Grabsch HI; Kavi V; Maughan NJ; Hillan KJ; Quirke P; Koeppen H
    Oncogene; 2006 Jun; 25(24):3445-57. PubMed ID: 16568095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Wnt signaling induced down regulation of mrhl long non-coding RNA in mouse spermatogonial cells.
    Akhade VS; Dighe SN; Kataruka S; Rao MR
    Nucleic Acids Res; 2016 Jan; 44(1):387-401. PubMed ID: 26446991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascl2 reinforces intestinal stem cell identity.
    Yan KS; Kuo CJ
    Cell Stem Cell; 2015 Feb; 16(2):105-6. PubMed ID: 25658363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TET2-BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter.
    Shang Y; Jiang T; Ran L; Hu W; Wu Y; Ye J; Peng Z; Chen L; Wang R
    J Biol Chem; 2022 Jul; 298(7):102095. PubMed ID: 35660018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.